This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

StockCall Research On Nu Skin And Avon: Survival Mode Engaged

Nu Skin Enterprises Inc. [ Free Research Report on NUS] [ 1 ], on the other hand, is looking to report 19 percent increase in its revenue for the fourth quarter of the year. It is scheduled to announce its fourth quarter financial numbers on February 6 th. However, not all is well with Nu Skin either. The company's business model is under considerable scrutiny after the Herbalife hullabaloo in the market. Like Herbalife, Nu Skin also operates on Multi Level Marketing model and thus is likely to be taken as a pyramid scheme. Nu Skin has the usual mix of anti ageing products and nutritional supplements in its portfolio. While the company is reporting consistent growth in its sales and profits, it is difficult to ignore that MLM companies have long been accused of providing misleading figures. Therefore, it is difficult to take the financial numbers at their face value.

Both Avon and Nu Skin are looking to expand their brands in international markets. While Avon started the process under its erstwhile CEO Andrea Jung and yielded lukewarm results, Nu Skin is about to go ahead with its five-year plan to consolidate its position in emerging markets like China.

Avon is also looking at dire times as it plans to slash its workforce by 1,500 in order to curtail costs. The company also made questionable decision to forego Coty offer of $24.75 per share. Its stock is now trading in the vicinity of $16 a pop. Apart from tough economic scene, both the companies seem to be dealing with myriad of internal problems like questionable business model and inefficiencies.

  1. Nu Skin Enterprises Inc. Technical Analysis [ ]


2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs